Role of Infiltrating CD4+ T Lympoocytes in Neuropathic Pain
Role of Infiltrating CD4+ T Lympoocytes in Neuropathic Pain
批准号:
7792213
负责人:
Ling Cao
金额:
$12.78万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-04-01 至 2012-03-31
关键词:
AffectAreaBiological ModelsBlocking AntibodiesBone MarrowCD4 Positive T LymphocytesCell surfaceCellsChimera organismComplicationConfocal MicroscopyFlow CytometryFunctional disorderHIV InfectionsHumanHypersensitivityImmune responseInterleukin-1Interleukin-6InterleukinsKnock-outKnockout MiceLeukocytesLigationLumbar spinal cord structureMature T-LymphocyteMeasuresMechanicsMicrogliaMusNecrosisNervous system structureNeuraxisNeurologicNude RatsPainPeripheralPrimary LesionProductionRodent ModelRoleSignal TransductionSpinal CordSpinal nerve structureT-LymphocyteTNFRSF5 geneTNFSF5 geneTactileTestingTimeWild Type Mouseadaptive immunitychronic paincytokineimmunoreactivityirradiationmechanical allodyniamonocytenerve injurypain behaviorpainful neuropathypublic health relevanceresponsesham surgeryspatial relationshiptherapeutic targettumor
中文摘要
描述(申请人提供):描述:尽管有许多研究描绘了神经免疫反应在神经病理性疼痛中的作用,但获得性免疫在神经病理性疼痛中的作用仍是一个研究不足的领域。无菌大鼠(缺乏成熟T淋巴细胞)和MHC II基因敲除(KO)小鼠(CD4+T淋巴细胞数量减少)在神经损伤后发生的机械性痛觉异常显著减少,这一事实突显了T淋巴细胞在神经病理性疼痛中的重要作用。本研究将描述神经损伤后中枢神经系统(CNS)T淋巴细胞的特点,并为其在中枢神经系统内的双向相互作用提供机制,从而建立一个研究神经病理性疼痛中可能的获得性免疫反应相关治疗靶点(如CD40-CD40L阻断)的模型系统。将使用一种成熟的神经病理性疼痛的啮齿动物模型,L5脊髓神经横断术(L5Tx),并将通过触觉敏感性反应来衡量小鼠的疼痛行为,触觉敏感性反应是人类机械过敏的代表。我们假设,神经损伤激活的CD4+T淋巴细胞渗透到脊髓的受累区域,并通过细胞表面CD40-CD40L的参与与小胶质细胞(单核细胞起源的中枢神经系统驻留细胞)相互作用,进一步促进小胶质细胞产生促炎细胞因子,这是维持长期疼痛行为的重要因素。本研究将进行以下三个方面的研究:1)L5Tx后脊髓小胶质细胞CD40表达与CD40L浸润性CD4+T淋巴细胞表达之间的时空关系;2)小胶质细胞CD40-CD4+T淋巴细胞CD40L结扎在L5Tx诱导的机械性超敏反应中的作用。公共卫生相关性:神经性疼痛是指由神经系统的原发病变或功能障碍引发或引起的疼痛,是最具破坏性的慢性疼痛之一,也是与艾滋病毒感染相关的常见神经系统并发症,在美国每年影响300-500万人。然而,它在很大程度上仍被视为次优。这项研究将进一步探讨获得性免疫在神经病理性疼痛的病理生理学中的作用,并可能为非成瘾治疗提供新的思路。
英文摘要
DESCRIPTION (provided by applicant): Description: Despite there being numerous studies delineating the role of neuroimmue responses in neuropathic pain, the role of adaptive immunity in neuropathic pain is yet an under-studied area. The fact that athymic rats (that lack mature T lymphocytes) and MHC II knockout (KO) mice (who have decreased numbers of CD4+ T lymphocytes) developed significantly reduced mechanical allodynia following nerve injury highlight the significant role of T lymphocytes in neuropathic pain. This proposal will characterize the central nervous system (CNS) infiltrating T lymphocytes after nerve injury and provide a mechanism for their bi-directional interactions in the CNS, thus establishing a model system for investigating possible adaptive immune response-related therapeutic targets (such as CD40-CD40L blockade) in neuropathic pain. A well-established rodent model of neuropathic pain, L5 spinal nerve transection (L5Tx), will be used and pain behavior in mice will be measured by the tactile sensitivity response, a representation of mechanical hypersensitivity in humans. We hypothesize that nerve injury activated CD4+ T lymphocytes infiltrate into the affected region of the spinal cord and interact with microglia (the CNS resident cells of monocyte origin) via cell surface CD40-CD40L engagement, further promoting microglial production of proinflammatory cytokines, factors important in maintaining long-lasting pain behavior. This study will be carried out following 3 specific aims: Determine 1) the temporal and spatial relationships between microglial expression of CD40 and infiltrating CD4+ T lymphocyte expression of CD40L in the lumbar spinal cord post-L5Tx, 2) the involvement of the microglial CD40-CD4+ T lymphocyte CD40L ligation in L5Tx-induced mechanical hypersensitivity by using CD4KO mice, bone marrow chimeras involving CD40KO mice, and a CD40 blocking antibody, and 3) the microglial proinflammatory cytokine production induced by the CNS CD40-CD40L interaction post-L5Tx. Public Health Relevance: Neuropathic pain, defined as pain initiated or caused by a primary lesion or dysfunction in the nervous system, is one of the most devastating kinds of chronic pain, and a common neurological complication associated with HIV infection, affecting 3-5 million people every year in the US. However, it is still largely treated sub-optimally. This study will further investigate the role of adaptive immunity in the pathophysiology of neuropathic pain and may yield ideas for new non-addictive treatments.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1017/s1740925x12000026
发表时间:
2011-05
期刊:
Neuron glia biology
影响因子:
--
作者:
[Malon JT, Maddula S, Bell H, Cao L]
通讯作者:
Cao L
DOI:
10.1186/1744-8069-8-88
发表时间:
2012-12-18
期刊:
Molecular pain
影响因子:
3.3
作者:
[Cao L, Beaulac H, Eurich A]
通讯作者:
Eurich A
HIV Tat-associated Sensory Neuropathy and the Contribution of Toll-like Receptor Pathway
-
批准号:10838798
-
项目类别:
-
资助金额:$35.5万
-
财政年份:2023
-
负责人:Ling Cao
-
依托单位:
Therapeutic potential of interferon (IFN)-beta for HIV-associated neurocognitive disorders (HAND) in opioid users
-
批准号:9411197
-
项目类别:
-
资助金额:$18.54万
-
财政年份:2017
-
负责人:Ling Cao
-
依托单位:
Therapeutic potential of interferon (IFN)-beta for HIV-associated neurocognitive disorders (HAND) in opioid users
-
批准号:9535975
-
项目类别:
-
资助金额:$16.1万
-
财政年份:2017
-
负责人:Ling Cao
-
依托单位:
Role of CD137L in peripheral nerve injury induced neuropathic pain
-
批准号:9177195
-
项目类别:
-
资助金额:$33.56万
-
财政年份:2016
-
负责人:Ling Cao
-
依托单位:
Role of CD137L in peripheral nerve injury induced neuropathic pain
-
批准号:9483794
-
项目类别:
-
资助金额:$33.19万
-
财政年份:2016
-
负责人:Ling Cao
-
依托单位:
Murine AIDS (LP-BM5) viral infection induced peripheral neuropathy - Role of CNS
-
批准号:7938606
-
项目类别:
-
资助金额:$17.07万
-
财政年份:2009
-
负责人:Ling Cao
-
依托单位:
Role of Infiltrating CD4+ T Lympoocytes in Neuropathic Pain
-
批准号:7471974
-
项目类别:
-
资助金额:$12.31万
-
财政年份:2008
-
负责人:Ling Cao
-
依托单位:
Role of Infiltrating CD4+ T Lympoocytes in Neuropathic Pain
-
批准号:7587314
-
项目类别:
-
资助金额:$12.56万
-
财政年份:2008
-
负责人:Ling Cao
-
依托单位:
Project 1: Cao
-
批准号:8883622
-
项目类别:
-
资助金额:$20.17万
-
财政年份:--
-
负责人:Ling Cao
-
依托单位:
Project 1: Cao
-
批准号:8529580
-
项目类别:
-
资助金额:$20.04万
-
财政年份:--
-
负责人:Ling Cao
-
依托单位:
Project 1: Cao
-
批准号:8466104
-
项目类别:
-
资助金额:$21.77万
-
财政年份:--
-
负责人:Ling Cao
-
依托单位:
Project 1: Cao
-
批准号:8689115
-
项目类别:
-
资助金额:$20.17万
-
财政年份:--
-
负责人:Ling Cao
-
依托单位:
Project 1: Cao
-
批准号:9087285
-
项目类别:
-
资助金额:$20.17万
-
财政年份:--
-
负责人:Ling Cao
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: